Hemangioma, Cavernous: Clinical Trials

1 trial for Hemangioma, Cavernous, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Hemangioma, Cavernous: new trials by email Literature Review of Hemangioma, Cavernous trials Research Report on Hemangioma, Cavernous

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation
Propranolol, DNA and RNA Analysis - Cerebral Cavernous Malformations
Phase 2TerminatedSt. Joseph's Hospital and Medical Center, Phoenix42018-01-242024-04-19

Narrower conditions

Hemangioma, Cavernous, Central Nervous System (1)

Broader conditions

Brain Diseases (1)  ·  Cardiovascular Abnormalities (1)  ·  Cardiovascular Diseases (1)  ·  Cavernous Sinus Syndromes (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Vascular Malformations (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Hemangioma (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Hemostatic Disorders (1)  ·  Neoplasms (1)

Interventions

DNA (1)  ·  Propranolol (1)

Sponsors

St. Joseph's Hospital and Medical Center, Phoenix (1)

Countries

United States (1)

Top investigators

Joseph Zabramski, MD (1)